featured
Impact of Therapeutic Heparin vs Prophylactic Heparin on Death, Mechanical Ventilation, and ICU Admission Among Hospitalized COVID-19 Patients
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
BMJ: British Medical Journal
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial
BMJ 2021 Oct 14;375(xx)n2400, M Sholzberg, GH Tang, H Rahhal, M AlHamzah, LB Kreuziger, FN Áinle, F Alomran, K Alayed, M Alsheef, F AlSumait, CE Pompilio, C Sperlich, S Tangri, T Tang, P Jaksa, D Suryanarayan, M Almarshoodi, LA Castellucci, PD James, D Lillicrap, M Carrier, A Beckett, C Colovos, J Jayakar, MP Arsenault, C Wu, K Doyon, ER Andreou, V Dounaevskaia, EK Tseng, G Lim, M Fralick, S Middeldorp, AYY Lee, F Zuo, BR da Costa, KE Thorpe, EM Negri, M Cushman, P JüniFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.